EcoDrugPlus

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSEBUG00000001148
Gene Symbol: APH1B
1 Cross references
317 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSEBUG00000016665
Gene Symbol: ABCB1
1 Cross references
154 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSEBUG00000002859
Gene Symbol: ABCC8
1 Cross references
253 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEBUG00000010364
Gene Symbol: BRAF
1 Cross references
218 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEBUG00000004942
Gene Symbol: BRAF
1 Cross references
219 Possible Orthologues:

Dna (Cytosine-5-)-Methyltransferase 1

Ensembl ID : ENSEBUG00000016760
Gene Symbol: DNMT1
1 Cross references
210 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSEBUG00000009439
Gene Symbol: TOP2A
1 Cross references
206 Possible Orthologues:

Dna Topoisomerase Ia

Ensembl ID : ENSEBUG00000000937
Gene Symbol: TOP1A
1 Cross references
274 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSEBUG00000006275
Gene Symbol: FAU
1 Cross references
327 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase A

Ensembl ID : ENSEBUG00000014288
Gene Symbol: FYNA
1 Cross references
278 Possible Orthologues:

Janus Kinase 2b

Ensembl ID : ENSEBUG00000015729
Gene Symbol: JAK2B
1 Cross references
271 Possible Orthologues:

Mapk Activated Protein Kinase 2b

Ensembl ID : ENSEBUG00000012046
Gene Symbol: MAPKAPK2B
1 Cross references
242 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).